Table 2 DREAM targets among Fanconi anemia, dyskeratosis congenita, and related DNA repair and telomere maintenance genes

From: Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

Gene name

Fanconi

DREAM pathway

Repressed by p53

 

Complementation

Target

 
 

Group or DC

Fischer et al. 17

Jaber et al. 101

BLM

 

BRCA1

FANCS

BRCA2

FANCD1

BRIP1 (BACH1)

FANCJ

DCLRE1B (Apollo)

 

 

DEK

 

DKC1 (Dyskerin)

Dyskeratosis Congen.

unclear

 

ERCC4 (XPF, RAD1)

FANCQ

no

 

FANCA

FANCA

FANCB

FANCB

FANCC

FANCC

 

FANCD2

FANCD2

FANCE

FANCE

 

FANCF

FANCF

no

 

FANCG

FANCG

 

FANCI

FANCI

FANCL

FANCL

 

FANCM

FANCM

FEN1

 

GAR1

 

unclear

PALB2

FANCN

RAD51

FANCR

RAD51C

FANCO

unclear

RECQL4

 

RTEL1

Dyskeratosis Congen.

unclear

 

SLX4 (BTBD12)

FANCP

no

 

Timeless

 

TINF2 (TIN2)

Dyskeratosis Congen.

no

 

UBE2T

FANCT

ACD

 

 

RIF1

 

 

PIF1 (RRM3)

 

 

RPA2

 

 

TRAIP

 

 

WRAP53 (TCAB1)

 

 
  1. Abbreviation: DC, dyskeratosis congenita
  2. To assess whether genes related to DNA repair, telomere maintenance103, 124 and Fanconi anemia99, 100, 105 are DREAM targets, data on mRNA regulation after p53 activation and binding of DREAM components E2F4, p130, LIN9 and LIN54 were retrieved from a database by Fischer et al.17 An updated data compilation can be accessed at www.targetgenereg.org.65 Jaber et al.101 have recently confirmed that p53 downregulates many of the Fanconi anemia genes by DREAM binding to CDE/CHR sites.